Top 10 HealthCare Devices and Supplies Capital Raises in the U.S. – December 16th-31st, 2024
Several interesting transactions closed in the HealthCare Devices and Supplies sector over the past two weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PIPE
- Kelyniam Global, engaged in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers, received development capital.
Merger/Acquisition
- Cloud Diagnostics Canada, manufacturer of remote patient monitoring platforms intended for healthcare enterprises, acquired by 1493907 B.C.
- Sherlock Biosciences, developer of a diagnostic platform designed to control disease in low-resource settings, acquired by Orasure Technologies.
Later Stage VC
- Aatru, developer of a medical device company intended to treat wounds and damaged skin, raised $350,000 of venture funding in the form of convertible debt.
- Agile Devices, developer of steerable and deflectable microcatheters intended to enhance the precision of interventional radiology procedures, raised $939,560 of venture funding.
- Pneuma Respiratory, developer of a digital breath-activated inhaler designed to provide therapeutic treatments for lung diseases, raised $7.34 million of venture funding.
Early Stage VC
- FastWave Medical, developer of intravascular devices designed for arterial to be safe, efficacious, and cost-effective, raised $19 million of venture funding in a deal led by Epic Venture Partners.
- SpinaFX, operator of a medical device company intended to bring minimally-invasive image-guided treatments to patients with back pain due to herniated discs, raised CAD 5.3 million of Series B venture funding.
- Waypoint Orthopedics, developer of surgical devices designed to make vertebral fixation safer and more efficient, raised $109,999 of venture funding.
Seed Round
- Flow Medical, developer of a thrombolysis catheter designed to treat pulmonary embolism, raised $5 million of seed funding from Everywhere Ventures, StageNext Fund and Harvard Business School Alumni Angels of Chicago.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcaredevicesandsupplies #healthcaredevice #healthcaresupplies
Tamara Williams
Managing Director
15+ years of experience in investment banking and financial structuring including private equity, acquisitions, fund management and raising debt capital within various sectors including real estate, oil and gas, hospitality, serviced offices, IT and trading. Advised on investment opportunities, capital structure, holding and tax structure. Skilled at conducting due diligence, company valuation and providing real estate development project oversight. International network extending from the US, UK, France, Russia, and the Middle East to Asia. Previously held several senior management positions in the financial industry. Master of Business Administration with Distinction from the University of Northampton UK. Higher National Diploma with Distinction from ABE UK. FINRA Series 7, 79, and 66 licenses.
- twilliams@castleplacement.com
- (385) 600-1871
 Tamara WilliamsManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers
